0 NASDAQ Companies - April 2, 2025eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCOExpanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully […]Read More
0 NASDAQ Companies - April 2, 2025ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company […]Read More
0 NASDAQ Companies - April 2, 2025FibroGen to Participate in the 24th Annual Needham Virtual Healthcare ConferenceSAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending […]Read More
0 NASDAQ Companies - April 2, 2025eXoZymes Provides Fourth Quarter and Full Year 2024 UpdateManagement to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) — Today, eXoZymes Inc. […]Read More
0 NASDAQ Companies - April 2, 2025Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage […]Read More
0 NASDAQ Companies - April 2, 2025BBSI Announces Appointment of Thomas McGinn as Senior Vice President of InsuranceVANCOUVER, Wash., April 02, 2025 (GLOBE NEWSWIRE) — Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business […]Read More
0 NASDAQ Companies - April 2, 2025Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital […]Read More
0 NASDAQ Companies - April 2, 2025NeuroPace Announces Refocusing of Product Portfolio— Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 — — Maintaining 2025 Revenue Guidance […]Read More
0 NASDAQ Companies - April 2, 2025Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of DirectorsWEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology […]Read More
0 NASDAQ Companies - April 2, 2025FormFactor Doubles Capacity at Taiwan Service Center to Meet Growing DemandLIVERMORE, Calif., April 02, 2025 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ: FORM), a leading provider of test and measurement technologies […]Read More